Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests Mindful Steps to help sedentary people with COPD or heart failure move more

Tests a remote program encouraging daily walking in adults with lung or heart disease.

Plain-language title generated from the registry record
Registry title: Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

Key facts

Where
Boston, United StatesSee the 2 sites

Where in United States

  • BIDMCBoston, United StatesTaking people
  • VA BostonBoston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beth Israel Deaconess Medical Center
Trial code
NCT05934565
Record updated
29 September 2026
Original description
The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.Read full original descriptionShow less

Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Chronic Cardiopulmonary Disease

The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.

Inclusion: Clinical diagnosis of COPD (defined as cigarette smoking history > 10 pack-years, and either a ratio of FEV1 to forced vital capacity < 0.70 or chest CT evidence of emphysema) OR clinical diagnosis of HF syndrome (with left ventricular systolic dysfunction or preserved ejection fraction and New York Heart Association Class 1-3); Medical clearance from provider to participate in an exercise program; Have an active email account; access to a computer device (desktop, laptop, tablet, or smartphone that supports the Fitbit app).

Exclusion: COPD or HF exacerbation in the previous month; Current participation in a cardiac or pulmonary rehabilitation program; Inability to collect at least 7 of 14 days of baseline step counts; Inability to ambulate.

ClinicalTrials.gov NCT05934565